Technical Analysis for ZFGN - Zafgen, Inc.
|Grade||Last Price||% Change||Price Change|
ZFGN closed down 0.21 percent on Friday, January 18, 2019, on 1.26 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
|See historical ZFGN trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||1,2,3 Retracement Bearish||Bearish Swing Setup||0.00%|
|Jan 18||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jan 18||Lower Bollinger Band Walk||Weakness||0.00%|
|Jan 18||Inside Day||Range Contraction||0.00%|
|Jan 18||Lower Bollinger Band Touch||Weakness||0.00%|
|Jan 18||Oversold Stochastic||Weakness||0.00%|
|Jan 17||1,2,3 Retracement Bearish||Bearish Swing Setup||-0.21%|
|Jan 17||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||-0.21%|
|Jan 17||Pocket Pivot||Bullish Swing Setup||-0.21%|
|Jan 17||New 52 Week Low||Weakness||-0.21%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Zafgen, Inc. is a biopharmaceutical company. The Company is engaged in improving the health and well-being of patients affected by obesity. Beloranib, the Company’s product candidate, is a twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including obesity and hyperphagia, or insatiable life-threatening hunger and hunger-related behaviors, in Prader-Willi Syndrome (PWS), craniopharyngioma-associated obesity, and severe obesity in the general population. PWS is a rare and complex genetic disorder characterized by physiologic, cognitive and behavioral symptoms, including hyperphagia and obesity. Craniopharyngioma is a rare form of benign brain tumor that occurs near the optic nerve, pituitary gland and hypothalamus. Approximately 30% to 50% of cases of craniopharyngioma are diagnosed in childhood and adolescence.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ZFGN news...
|52 Week High||12.355|
|52 Week Low||4.51|
|200-Day Moving Average||8.2585|
|50-Day Moving Average||6.3704|
|20-Day Moving Average||4.9595|
|10-Day Moving Average||4.928|
|Average True Range||0.332|
|Chandelier Exit (Long, 3 ATRs )||4.574|
|Chandelier Exit (Short, 3 ATRs )||5.506|
|Upper Bollinger Band||5.3192|
|Lower Bollinger Band||4.5998|
|Percent B (%b)||0.19|
|MACD Signal Line||-0.4395|
|Market Cap||130.27 Million|
|Num Shares||27.5 Million|
|Price-to-Earnings (P/E) Ratio||-2.52|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||5.27|
|Resistance 3 (R3)||5.25||5.07||5.18|
|Resistance 2 (R2)||5.07||4.93||5.07||5.15|
|Resistance 1 (R1)||4.90||4.85||4.99||4.92||5.12|
|Support 1 (S1)||4.55||4.58||4.64||4.57||4.36|
|Support 2 (S2)||4.37||4.50||4.37||4.33|
|Support 3 (S3)||4.20||4.37||4.30|
|Support 4 (S4)||4.22|